Beside the surgical treatment and the parenteral (and enteral) nutrition, the pharmacological modulation using associations of insulin and fenofibrate plus β1-selective antagonists or insulin and sitagliptin plus β1-selective antagonists represents a very effective tool for decreasing the hyperglycemia of burned patients. This evidence concerns the gene INS and Hyperglycemia.